¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary refractory anemia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
¿µ¹® iron deficiency anemia ÇÑ±Û Ã¶°áÇ̺óÇ÷
¼³¸í   
  ÀûÇ÷±¸ÀÇ ±â´ÉÀº »ê¼Ò¸¦ ¿î¹ÝÇϴµ¥ ÀÖ´Ù. ÀûÇ÷±¸ ¼Ó¿¡ »ê¼Ò¿Í °áÇÕÀ» ÇÏ¿© »ê¼Ò¸¦ ¿î¹ÝÇϴ Ç÷»ö¼Ò¶ó´Â ¹°ÁúÀÌ ÀÖ´Ù. Ã¶Àº ÀÌ Ç÷»ö¼ÒÀÇ Áß¿äÇÑ ºÎºÐÀ» ÀÌ·ç´Â °ÍÀ¸·Î Ã¶ÀÌ ¾øÀ¸¸é Ç÷»ö¼Ò°¡ ¸¸µé¾îÁú ¼ö°¡ ¾ø´Ù. Ç÷»ö¼Ò°¡ ¾øÀ¸¸é ¿ª½Ã ÀûÇ÷±¸µµ ¸¸µé¾îÁöÁö ¾ÊÀ¸¹Ç·Î Ã¼³»¿¡ Ã¶ÀÌ ºÎÁ·Çϸ頺óÇ÷ÀÌ »ý±ä´Ù. À̠ö°áÇ̼º ºóÇ÷Àº ºóÇ÷ÀÇ ¿øÀΠÁß¿¡¼­ °¡Àå ÈçÇÑ °ÍÀÌ´Ù(¾à 25%¸¦ Â÷ÁöÇÑ´Ù). Ã¶ÀúÀå·®ÀÇ ÀúÇÏ-°áÇÌ, Ç÷ûö³óµµÀÇ ÀúÇÏ, Æ®¶õ½ºÆä¸°·® »ó½Â, Æ®¶õ½ºÆä¸°Æ÷È­µµÀÇ ÀúÇÏ, Ç÷»ö¼Ò³óµµ ¶Ç´Â Ç츶ÅäÅ©¸®Æ®ÀÇ ÀúÇÏ, Àú»ö¼Ò¼º´ëÀûÇ÷±¸¸¦ Æ¯Â¡À¸·Î Çϴ ºóÇ÷·Î¼­, »ýü ³»¿¡¼­ Ã¶ÀÌ Àå±â¿¡ °ÉÃÄ °áÇ̵Ǹ砱נ¶§¹®¿¡ Ç÷»ö¼Ò »ý»ê °¨¼Ò¿¡ ÀÇÇØ ÀϾ´Ù. Ã¢ÀÚ¿¡¼­ÀǠöÈí¼ö·® ºÎÁ·, Ã¶ÀÇ ¼ö¿ä Áõ´ë(À¯¾Æ±â, »çÃá±â, ÀÓ½Å), Ã¶¼Ò½Ç°úÀ×(ÃâÇ÷)¿¡ ÀÇÇØ ÀϾ¸ç, Æ¯È÷ »çÃá±â¿¡¼­ Æó°æ±â±îÁöÀÇ ¿©¼º¿¡°Ô ¸¹´Ù. Áõ»óÀ¸·Î¼­´Â ¾ó±¼Ã¢¹é, ÇǷΰ¨, ÇǺÎâ¹é, ¼ÕÅé º¯È­(½ºÇ¬ ¸ð¾ç) µîÀ» ³ªÅ¸³½´Ù. ±¸°­ ¿µ¿ª¿¡¼­´Â ÇôÀÇ Á¢ÃËÅë, ¹ßÀû, °ÇÁ¶°¨, »ïÅ´°ï¶õÀ» ¼ö¹ÝÇϸé Ç÷¯¸Ó-ºó½¼(Plummer-Vinson)ÁõÈıºÀ̶ó°í ÇÑ´Ù. Ç÷¾× ¼Ò°ßÀº Ç÷ûöÀº ÀúÇÏÇϸç, Ã¶°áÇÕ´É·ÂÀÇ »ó½Â, Àú»ö¼Ò¼º ÀÛÀºÀûÇ÷±¸¼ºÀ» ³ªÅ¸³½´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary constriction
    ÀÌÂ÷ÇùÂø
  • secondary culture
    ÀÌÂ÷¹è¾ç
  • secondary dentin
    ÀÌÂ÷»ó¾ÆÁú
  • secondary dentition
    ÀÌÂ÷Ä¡¾Æ
  • secondary disease
    ¼Ó¹ßº´, ¼Ó¹ßÁúȯ
  • secondary dysmenorrhea
    ¼Ó¹ß¿ù°æÅë
  • secondary ending
    ÀÌÂ÷Á¾¸»
  • secondary evoked response
    ÀÌÂ÷À¯¹ß¹ÝÀÀ
  • secondary gout
    ÀÌÂ÷Åëdz
  • secondary hemorrhage
    ¼Ó¹ßÃâÇ÷, ÀÌÂ÷ÃâÇ÷
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • secondary hypogonadism
    ¼Ó¹ß»ý½Ä»ùÀúÇÏÁõ, ¼Ó¹ß»ý½Ä¼±ÀúÇÏÁõ
  • secondary immune response
    ÀÌÂ÷¸é¿ª¹ÝÀÀ
  • secondary infection
    ÀÌÂ÷°¨¿°, ¼Ó¹ß°¨¿°
  • secondary keratitis
    ¼Ó¹ß°¢¸·¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • iron deficiency anemia
    ö°áÇ̺óÇ÷
  • macrocytic anemia
    Å«ÀûÇ÷±¸ºóÇ÷
  • megaloblastic anemia
    °Å´ëÀûÇ÷¸ð±¸ºóÇ÷
  • pernicious anemia
    ¾Ç¼ººóÇ÷
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary biliary cirrhosis
    ¼Ó¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • secondary dentition
    (¢¡permanent tooth) °£´Ï, ¿µ±¸Ä¡¾Æ
  • secondary disease
    ¼Ó¹ßº´
  • secondary dysmenorrhea
    ÀÌÂ÷¿ù°æÅë
  • secondary ending
    ÀÌÂ÷Á¾¸»
  • secondary gout
    ÀÌÂ÷Åëdz
  • secondary hemorrhage
    ¼Ó¹ßÃâÇ÷, ÀÌÂ÷ÃâÇ÷
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • secondary hypogonadism
    ¼Ó¹ß»ý½Ä»ùÀúÇÏÁõ
  • secondary infection
    ÀÌÂ÷°¨¿°
  • secondary keratitis
    ¼Ó¹ß°¢¸·¿°
  • secondary nodule
    (¢¡germinal center) Á¾ÀÚÁß½É, ¹èÁß½É
  • secondary pneumonia
    ¼Ó¹ßÆó·Å
  • secondary attack rate
    ÀÌÂ÷¹ßº´·ü
  • secondary evoked response
    ÀÌÂ÷À¯¹ß¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • refractory rickets
    ³­Ä¡±¸·çº´(Ññö½ ׬ܻ)
  • refractory state
    ºÒÀÀ»óÅÂ, ¹«¹ÝÀÀ»óÅÂ
  • relative refractory period
    »ó´ë(Àû) ºÒÀÀ±â(ßÓÓßîÜÝÕëëÑ¢).
  • Cooleys anemia
    Äí¿ï¸®ºóÇ÷.
  • Cooleys anemia
    Äí¿ï¸®ºóÇ÷
  • Cooleys anemia
    Äí¿ï¸®ºóÇ÷.
  • Diamond-Blackfan anemia
    ´ÙÀ̾Ƹóµå-ºí·¢ÆÇ ºóÇ÷
  • Fanconi anemia
    ÆÇÄÚ´Ï ºóÇ÷
  • Fanconis anemia
    ÆÇÄڴϺóÇ÷
  • Iron deficiency anemia
    ö°áÇ̼ººóÇ÷(ôÑÌÀù¹àõÞ¸úì)
  • Mediterranean anemia
    ÁöÁßÇØºóÇ÷.
  • achlorhydric anemia
    ¹«À§»ê¼º ºóÇ÷(¡­àõÞ¸úì).
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(¡­éÁúìàõÞ¸úì).
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(?ËíÌ´ËÛË×Ì´).
  • acute posthemorrhagic anemia
    ±Þ¼º ÃâÇ÷Èļº ºóÇ÷(¡­õóúìý­àõÞ¸úì).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary anemia
    ¼Ó¹ß¼º ºóÇ÷(áÙÛ¡àõ Þ¸úì).
  • secondary anemia
    ¼Ó¹ß¼º ºóÇ÷(áÙÛ¡àõ Þ¸úì)
  • secondary hemolytic anemia
    ¼Ó¹ß¼º ¿ëÇ÷¼º ºóÇ÷(áÙÛ¡àõéÁúìàõÞ¸úì).
  • secondary hemolytic anemia
    ¼Ó¹ß¼º ¿ëÇ÷¼º ºóÇ÷(áÙÛ¡àõéÁúìàõÞ¸úì)
  • absolute refractory period
    Àý´ëºÒÀÀ±â(¡­ÝÕëëÑ¢)
  • histamin refractory
    È÷½ºÅ¸¹Î¹«¹ÝÀÀ¼º(¡­ÙíÚãëëàõ)ÀÇ.
  • platelet immunologic refractory state
    Ç÷¼ÒÆÇ¸é¿ªÇÐÀû ºÒÀÀ»óÅÂ(ÝÕëëßÒ÷¾)
  • refractory edema
    Ä¡·áºÒÀÀ¼º ºÎÁ¾.
  • refractory edema
    Ä¡·áºÒÀÀ¼º ºÎÁ¾(ö½ÖûÝÕÒöàõÝ©ðþ)
  • refractory investment
    ³»È­¸Å¸ôÁ¦(Ò±ûýØØÙÒð¥).
  • refractory otalgia
    ³­Ä¡(¼º) ÀÌÅë
  • refractory otalgia
    ³­Ä¡¼º ÀÌÅë(Ññö½àõì¼÷Ô)
  • refractory rickets
    ³­Ä¡±¸·çº´(Ññö½ ׬ܻ).
  • refractory rickets
    ³­Ä¡±¸·çº´(Ññö½ ׬ܻ)
  • refractory state
    ºÒÀÀ»óÅÂ, ¹«¹ÝÀÀ»óÅÂ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Secondary osteogenic bud
    ÀÌÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÇü¼º¾Æ
  • Secondary ossification center
    ÀÌÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary ossification center [Epiphyseal ossification cente
    ÀÌÂ÷»À¹ß»ýÁ᫐ [»À³¡»À¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary bone trabecula
    ÀÌÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¼ÒÁÖ
  • Secondary dentin
    ÀÌÂ÷»ó¾ÆÁú
    [¿¾ ¿ë¾î] ÀÌÂ÷»ó¾ÆÁú
  • Secondary nodule
    ÀÌÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÌÂ÷¼ÒÀý
  • Secondary villus
    ÀÌÂ÷À¶¸ð
    [¿¾ ¿ë¾î] ÀÌÂ÷À¶¸ð
  • Secondary pregnancy
    ÀÌÂ÷ÀÓ½Å
    [¿¾ ¿ë¾î] ÀÌÂ÷ÀÓ½Å
  • Secondary spermatocyte
    ÀÌÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷Á¤¸ð¼¼Æ÷
  • Secondary spermatocyte
    ÀÌÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] Á¦ÀÌÁ¤¸ð¼¼Æ÷
  • Secondary nasal septum
    ÀÌÂ÷ÄÚÁß°Ý
    [¿¾ ¿ë¾î] ÀÌÂ÷ºñÁß°Ý
  • Secondary hair follicle
    ÀÌÂ÷ÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷¸ð³¶
  • Secondary sponge bone
    ÀÌÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÌÂ÷ÇØ¸é°ñ
  • Secondary pulmonary lobule
    ÀÌÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÌÂ÷Æó¼Ò¿±
  • Palatine process [Secondary palate]
    ÀÔõÀåµ¹±â [ÀÌÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] ±¸°³µ¹±â(ÀÌÂ÷±¸°³)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary charge effect
    ÀÌÂ÷ ÇÏÀüÈ¿°ú(ì£ó­ùÃï³üùÍý)
  • secondary culture
    ÀÌÂ÷ ¹è¾ç(ì£ó­ÛÆå×)
  • secondary deficiency
    ÀÌÂ÷ °áÇÌ(ì£ó­ÌÀù¹)
  • secondary derived protein
    ÀÌÂ÷ À¯µµ´Ü¹éÁú(ì£ó­ë¯ÓôÓ±ÛÜòõ)
  • secondary electron
    ÀÌÂ÷ ÀüÀÚ(ì£ó­ï³í­)
  • secondary fluor
    ÀÌÂ÷ Çü±¤Á¦(ì£ó­û«ÎÃð¥)
  • secondary hydration shell
    ÀÌÂ÷(ì£ó­) ¼öÈ­ â©ûù ²®Áú
  • secondary ionization
    ÀÌÂ÷(ì£ó­) ÀÌ¿ÂÈ­(ûù)
  • secondary ion mass spectrometry
    ÀÌÂ÷ ÀÌ¿ÂÁú·®ºÐ±¤¹ý(ì£ó­òõÕáÝÂÎÃÛö)
  • secondary isotope effect
    ÀÌÂ÷ µ¿À§¿ø¼ÒÈ¿°ú(ì£ó­ÔÒêÈêªáÈüùÍý)
  • secondary lysosome
    ÀÌÂ÷(ì£ó­) ¶óÀ̼ҼØ
  • secondary malnutrition
    ÀÌÂ÷ ¿µ¾ç½ÇÁ¶(ì£ó­ç½å×ã÷ðà)
  • secondary messenger
    ÀÌÂ÷ Àü·É (ì£ó­îîÖµ)
  • secondary metabolite
    ÀÌÂ÷ ´ë»ç¹°(ì£ó­ÓÛÞóÚª)
  • secondary plant constituent
    ÀÌÂ÷ ½Ä¹°¼ººÐ(ì£ó­ãÕÚªà÷ÝÂ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary tuberculosis
    ÀÌÂ÷¼º°áÇÙ
  • secondary X-ray
    ÀÌÂ÷X¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RA   1) Refractory Anemia
  2) Rheumatoid Arthritis ? Arthritis
  3...
RAEB Refractory Anemia with Excess of Blasts
RAEB-T Refractory Anemia with Excess Blasts in Transformation
RARS Refractory Anemia with Ringed Sideroblast
  = AISA
IARSA idiopathic acquired refractory sideroblastic anemia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SLC Secondary Lymphoid-tissue Chemokine
SP Secondary Polycythaemia
SIMS Secondary ion mass spectroscopy
SP Secondary progressive
ToF-SIMS Time of Flight Secondary Ion Mass Spectrometry
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • secondary efflorescence
    ¼Ó¹ß¼º ¹ßÁø
  • secondary epithelization vestibuloplasty
    ÀÌÂ÷¼º »óÇÇÈ­ ±¸°­ ÀüÁ¤¼ú
  • secondary gain
    ÀÌÂ÷ À̵æ
    °£Á¢ÀûÀÎ À̵æÀ¸·Î¼­ º¸Åë Áúº´À̳ª ¼è¾àÀ¸·ÎºÎÅÍ ¾ò¾îÁø´Ù. À̰ÍÀº Àڽſ¡°Ô ÇØ·Î¿î Àǹ«³ª Ȱµ¿À» ÇÇÇϰí Åë»óÀûÀ¸·Î´Â µµ¿ÍÁÖÁö ¾Ê´Â »ç¶÷À¸·ÎºÎÅÍ ÁöÁö¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÑ´Ù.
  • secondary healing
    ÀÌÂ÷Àû Ä¡À¯, À̱â À¯ÇÕ
  • secondary herpes simplex
    ÀÌÂ÷Àû ±¸¼ø Æ÷Áø
  • secondary hyperalgesia
    ¼Ó¹ß¼º Åë°¢ °ú¹Î, ÀÌÂ÷Àû Åë°¢ °ú¹Î
    µ¿ÀǾî=secondary hy
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´É Ç×Áø, ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´É Ç×ÁøÁõ
  • secondary hypertrophic osteoarthropathy
    ¼Ó¹ß¼º ºñ´ë¼º °ñ °üÀýº´Áõ
  • secondary impression
    ÀÌÂ÷ Àλó
  • secondary inoculation
    ÀÌÂ÷ Á¢Á¾
  • secondary lesion
    ÀÌÂ÷¼º º´º¯, ÀÌÂ÷ ¹ßÁø, ¼Ó¹ßÁø
  • secondary local muscle soreness
    ¼Ó¹ß¼º ±¹¼Ò ±Ùµ¿Åë
  • secondary occlusal trauma
    ¼Ó¹ß¼º ±³ÇÕ ¿Ü»ó
    ÀÌ¹Ì Ä¡ÁÖ ÁúȯÀÌ ÀÖ´Â Ä¡¾Æ¿¡ °¡ÇØÁø °úµµÇÑ ±³ÇÕ·ÂÀ¸·Î ÀÎÇÑ Ä¡ÁÖ Á¶Á÷ÀÇ ¿Ü»ó.
  • secondary ossification center
    ÀÌÂ÷ °ñÈ­ Áß½É
  • secondary osteon
    ÀÌÂ÷ »À ´ÜÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
refractory state Subnormal excitability immediately following a response to previous excitation; the state is divided into absolute and relative phases.
(05 Mar 2000)
relative refractory period The period between the effective refractory period and the end of the refractory period; fibres then respond only to high intensity stimuli and the impulses conduct more slowly than normally.
(05 Mar 2000)
primary refractory anaemia Any of a group of anaemic conditions in which there is persistent, frequently advanced anaemia that is not successfully treated by any means except blood transfusions, and that is not associated with another primary disease.
(05 Mar 2000)
effective refractory period The period during which impulses may appear but are too weak to be conducted; the longest interval between adequate stimuli, falling just short of the time necessary to allow a propagated response to be evoked in a tissue by the second stimulus; it differs from the functional refractory period in that it is a measure of stimulus interval rather than response interval of time.
(05 Mar 2000)
total refractory period The absolute refractory period plus the relative refractory period.
(05 Mar 2000)
functional refractory period The minimum interval possible between successive responses to stimulation of a tissue.
(05 Mar 2000)
CS2 secondary alkylsulfohydrolase <enzyme> From comamonas terrigena
Registry number: EC 3.1.6.-
Synonym: cs2 sa sulfohydrolase
(26 Jun 1999)
protein structure, secondary The stage in the development of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to alpha helices and beta sheets. This is the first folding level of protein building.
(12 Dec 1998)
secondary Second or inferior in order of time, place or importance, derived from or consequent to a primary event or thing.
Origin: L. Secundarius, secundus = second
(18 Nov 1997)
secondary abdominal pregnancy A condition in which the embryo or foetus continues to grow in the abdominal cavity after its expulsion from the fallopian tube or other seat of its primary development.
Synonym: abdominocyesis.
(05 Mar 2000)
secondary adhesion Delayed closure of two granulating surfaces.
Synonym: secondary adhesion, secondary union.
(05 Mar 2000)
secondary adrenocortical insufficiency Adrenocortical insufficiency caused by failure of ACTH secretion resulting from anterior pituitary disease or inhibition of ACTH production resulting from exogenous steroid therapy.
(05 Mar 2000)
secondary aerodontalgia Pain referred to the dental area from an area of aerosinusitis.
(05 Mar 2000)
secondary agammaglobulinaemia Immunodeficiency in which there is no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins such as occurs in familial idiopathic hypercatabolic hypoproteinaemia or in defects associated with the nephrotic syndrome.
Synonym: secondary agammaglobulinaemia, secondary antibody deficiency, secondary hypogammaglobulinaemia.
(05 Mar 2000)
secondary alcohol An alcohol characterised by the bivalent atom group
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary school
    Áßµî Çб³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á